INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,923 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
BV
Baltrus VictoriaChief Accounting Officer
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$9,698
432 sh
Jun 2, 2026Jun 4, 2026
Page 713 of 1724
← PrevNext →
traded Jun 2, 2026
+2d
SEC Form 4

Evidence

16
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$217K
9,668 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

16
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$378K
40.6K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

15
KC
Keswani Sanjay ChandruChief Medical Officer
NBIXNEUROCRINE BIOSCIENCES INC
Tax withholding
F$268K
1,733 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

15
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Tax withholding
F$576K
23.6K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

15
GA
Gilboa David AbrahamDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Tax withholding
F$576K
23.6K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

14
GE
Grabscheid EduardCHIEF FINANCIAL OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$58K
682 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

14
CR
Chambers RebeccaChief Financial Officer
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$98K
1,961 sh
Jun 4, 2026Jun 4, 2026
traded Jun 4, 2026
+0dSEC Form 4

Evidence

14
GE
Grabscheid EduardCHIEF FINANCIAL OFFICER
FROGJFrog Ltd
Open-market sale · 10b5-1 plan
SELL$160K
1,902 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

14
CR
Chambers RebeccaChief Financial Officer
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$79K
1,600 sh
Jun 4, 2026Jun 4, 2026
traded Jun 4, 2026
+0dSEC Form 4

Evidence

14
TS
Tabak ShawnCHIEF FINANCIAL OFFICER
PRCHPorch Group, Inc.
Open-market sale
SELL$43K
3,944 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

14
HH
Harris Isaac HosojiroDirector
LITELumentum Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$1.42M
1,416 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
9,816 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
CC
Cantwell Wayne CDirector
AIPArteris, Inc.
Grant or award
A—
7,839 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
GA
Gilboa David AbrahamDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
9,816 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
GA
Gilboa David AbrahamDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
9,816 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
SL
Schwartz LarissaSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$327K
2,500 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
LS
Landman SamDirector
HIPOHippo Holdings Inc.
Grant or award
A—
4,808 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
11.0K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
11.0K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
GA
Gilboa David AbrahamDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
11.0K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
GA
Gilboa David AbrahamDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
11.0K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
GA
Gilboa David AbrahamDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
44.6K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
SL
Schwartz LarissaSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$329K
2,500 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
BC
Bauza CarmenDirector
ZUMZZumiez Inc
Grant or award
A—
4,110 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

13
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
44.6K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
DJ
Dunne James J. IIIDirector
CHYMChime Financial, Inc.
Grant or award
A—
10.8K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
BB
Baer Daniel BrooksDirector
GRNDGrindr Inc.
Grant or award
A—
5,205 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
HM
Harkless Guy MatthewDirector
ZUMZZumiez Inc
Grant or award
A—
4,110 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

13
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Option exercise
M—
9,816 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

13
VL
von Ahn LuisDirector
FIGFigma, Inc.
Grant or award
A—
12.4K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

12
HJ
Hay Laura JDirector
HIPOHippo Holdings Inc.
Grant or award
A$64K
2,502 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

12
HC
Holliday Susan ClaireDirector
HIPOHippo Holdings Inc.
Grant or award
A$64K
2,502 sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence

12
CK
Chaney Brian KSenior Vice President
WYWEYERHAEUSER CO
Tax withholding
F$85K
3,491 sh
Jun 3, 2026Jun 4, 2026
traded Jun 3, 2026
+1dSEC Form 4

Evidence

12
RS
Ravella SatishChief Accounting Officer
ZETAZeta Global Holdings Corp.
Gift
G—
7,968 sh
Jun 4, 2026Jun 4, 2026
traded Jun 4, 2026
+0dSEC Form 4

Evidence

12
SK
Spears KelvinDirector
NUTXNutex Health Inc.
Other acquisition or disposition
J—
2,519 sh
Jun 4, 2026Jun 4, 2026
traded Jun 4, 2026
+0dSEC Form 4

Evidence

12
FA
Fehring Nicolas A.VP, Controller
IBMINTERNATIONAL BUSINESS MACHINES CORP
Gift
G—
400 sh
Jun 4, 2026Jun 4, 2026
traded Jun 4, 2026
+0dSEC Form 4

Evidence

11
MA
McGuire AnnieEVP, General Counsel
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$69K
1,400 sh
Jun 4, 2026Jun 4, 2026
traded Jun 4, 2026
+0dSEC Form 4

Evidence

11
MA
McGuire AnnieEVP, General Counsel
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$89K
1,776 sh
Jun 4, 2026Jun 4, 2026
traded Jun 4, 2026
+0dSEC Form 4

Evidence

11
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Open-market sale · 10b5-1 plan
SELL$1.40M
150.3K sh
Jun 2, 2026Jun 4, 2026
traded Jun 2, 2026
+2dSEC Form 4

Evidence